| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA432534
Max Phase: Preclinical
Molecular Formula: C16H22NNaO7
Molecular Weight: 341.36
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(C)(C)OC(=O)[C@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C(C(C)(C)C)O[C@H]12.[Na+]
Standard InChI: InChI=1S/C16H23NO7.Na/c1-15(2,3)10-8(13(20)21)17-11(19)7(12(17)23-10)9(18)14(22)24-16(4,5)6;/h7,9,12,18H,1-6H3,(H,20,21);/q;+1/p-1/t7-,9+,12+;/m0./s1
Standard InChI Key: DZJYERSNAGACBN-TTWAZCPVSA-M
Associated Targets(non-human)
blaZ Beta-lactamase (285 Activities)
Beta-lactamase (42 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 341.36 | Molecular Weight (Monoisotopic): 341.1475 | AlogP: 0.85 | #Rotatable Bonds: 3 |
| Polar Surface Area: 113.37 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.65 | CX Basic pKa: | CX LogP: 0.52 | CX LogD: -2.80 |
| Aromatic Rings: 0 | Heavy Atoms: 24 | QED Weighted: 0.58 | Np Likeness Score: 0.51 |
References
| 1. Wild H, Metzger K. (1993) Substituted 6-alkyloxapenems: potent -lactamase inhibitors: synthesis and biological characterization, 3 (11): [10.1016/S0960-894X(01)80926-4] |
Source
Source(1):